Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 1 hour ago
Dates of 2027 SAWP meetings and submission deadlines Scientific advice, protocol assistance, qualification of biomarkers and parallel HTACG/EMA Joint Scientific Consultation requests
about 2 hours ago
Dates of 2027 SAWP meetings and submission deadlines Scientific advice, protocol assistance...
Human medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation: 09/11/2022, Revision: 3, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Pyrukynd, mitapivat, Date of authorisation...
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Date of authorisation...
Sixteenth industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, from 2 July 2026, 12:30 (CEST) to 2 July 2026, 17:30 (CEST)
about 3 hours ago
Sixteenth industry stakeholder platform on research and development support, European Medicines Agency...
Presentation - SPOR and XEVMPD status update webinar - Q3 2026
about 5 hours ago
Presentation - SPOR and XEVMPD status update webinar - Q3 2026
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course (Bucharest) - October 2026, Hotel Capital Plaza Bucharest, from 29 October 2026, 08:00 (CET) to 30 October 2026, 12:00 (CET)
about 22 hours ago
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course (Bucharest) - October 2026...
Human medicines European public assessment report (EPAR): Ebixa, memantine, Date of authorisation: 15/05/2002, Revision: 27, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Ebixa, memantine, Date of authorisation...
Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 4, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation...
Meeting Summary - PCWP/HCPWP joint meeting
about 23 hours ago
Meeting Summary - PCWP/HCPWP joint meeting
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Mepsevii, vestronidase alfa, Date of authorisation: 23/08/2018, Revision: 9, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Mepsevii, vestronidase alfa, Date of...
Human medicines European public assessment report (EPAR): Tolura, telmisartan, Date of authorisation: 04/06/2010, Revision: 15, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Tolura, telmisartan, Date of authorisation...